Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Luye Pharma Group enter agreement for rights to Seroquel and Seroquel XR in the UK, China and other international markets
-
Tagrisso receives positive EU CHMP opinion for 1st-line treatment of EGFR-mutated non-small cell lung cancer
-
AstraZeneca reports results from the ARCTIC trial in third-line non-small cell lung cancer
-
US FDA approves Tagrisso as 1st-line treatment for EGFR-mutated non-small cell lung cancer
-
Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR
-
1st-line Tagrisso demonstrates sustained benefit post progression in patients with EGFR-mutated non-small cell lung cancer
-
AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
-
US FDA accepts Biologics License Application for moxetumomab pasudotox in hairy cell leukaemia
-
The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer
-
Lokelma approved in the EU for the treatment of adults with hyperkalaemia
Latest articles and press releases
All of our latest press releases and articles are available to explore
